Affordable Access

Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes.

Authors
  • Ling, Sharon Sheue Nee
  • Magosso, Enrico
  • Khan, Nurzalina Abdul Karim
  • Yuen, Kah Hay
  • Barker, Susan Anne
Type
Published Article
Journal
Drug development and industrial pharmacy
Publication Date
Mar 01, 2006
Volume
32
Issue
3
Pages
335–345
Identifiers
PMID: 16556538
Source
Medline
License
Unknown

Abstract

A liposome system was evaluated for oral delivery of a poorly bioavailable hydrophilic drug. The system was prepared from proliposome, which consisted of negatively charged phosphatidylcholine, whereas cefotaxime was chosen as the model drug. An in vivo study was carried out on nine rats according to a three-way crossover design to compare the oral bioavailability of cefotaxime from the liposomal formulation with that of an aqueous drug solution and a physical mixture of cefotaxime with blank liposomes. The results indicated that the extent of bioavailability of cefotaxime was increased approximately 2.7 and 2.3 times compared with that of the aqueous solution and the physical mixture, respectively. In a separate study, simultaneous determination of cefotaxime in intestinal lymph (collected from the mesenteric lymph duct) and in plasma (collected from the tail vein) revealed that its concentration was consistently higher in the lymph than in the plasma when administered via the liposomal formulation, whereas the reverse was observed with the aqueous solution. Thus, the results indicated that the liposomes system has the potential of increasing the oral bioavailability of poorly bioavailable hydrophilic drugs and also promote their lymphatic transport in the intestinal lymph.

Report this publication

Statistics

Seen <100 times